Patents Assigned to CLEARNOTE HEALTH, INC.
  • Patent number: 11634748
    Abstract: Methods are provided for the epigenetic analysis of cell-free DNA using organic boranes to convert oxidized 5-methylcytosine residues in the cell-free DNA to dihydrouracil (DHU) residues. Cell-free DNA is contacted with an organic borane selected to successively bring about reduction, deamination, and decarboxylation of oxidized 5-methylcytosine residues such as 5-carboxymethylcytosine and 5-formylcytosine, resulting in DHU residues in place thereof. Following amplification, the treated cell-free DNA is sequenced, with the DHU residues read as thymine residues. Reaction mixtures, kits and additional methods are also provided, as are related methods for the epigenetic analysis of DNA, including cell-free DNA.
    Type: Grant
    Filed: February 13, 2019
    Date of Patent: April 25, 2023
    Assignee: CLEARNOTE HEALTH, INC.
    Inventors: Patrick A. Arensdorf, Damek Spacek